Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer-Reference-Cited by-同舟云学术

Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer

Published:2016-11-16 Issue:11 Volume:151 Page:e162743
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Haisley Kelly R.¹,Laird Amy E.²,Nabavizadeh Nima³,Gatter Ken M.⁴,Holland John M.³,Vaccaro Gina M.⁵,Thomas Charles R.³,Schipper Paul H.⁶,Hunter John G.¹,Dolan James P.¹

Affiliation:

1. Division of Gastrointestinal and General Surgery, Department of Surgery, Oregon Health and Science University, Portland

2. Division of Biostatistics, School of Public Health, Oregon Health and Science University, Portland

3. Department of Radiation Medicine, Oregon Health and Science University, Portland

4. Department of Pathology, Oregon Health and Science University, Portland

5. Division of Medical Oncology, Department of Medicine, Oregon Health and Science University, Portland

6. Division of Cardiovascular and General Thoracic Surgery, Department of Surgery, Oregon Health and Science University, Portland

Publisher

American Medical Association (AMA)

Subject

Surgery

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitive Chemoradiotherapy versus Trimodality Therapy for Locally Advanced Esophageal Adenocarcinoma: A Multi-Institutional Retrospective Cohort Study;Cancers;2024-08-15

2. Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?;Journal of Cancer Research and Clinical Oncology;2024-03-27

3. Finding the Optimal Time to Esophagectomy After Systemic Therapy Would be Finding a Lost Princess or Prince;Annals of Surgical Oncology;2024-03-22

4. Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma;Cancer Medicine;2024-03

5. Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study;Annals of Surgical Oncology;2024-01-27